Quetiapine-associated cholestasis causing lipoprotein-X and pseudohyponatraemia

Journal of Clinical Pathology

Volumn 63, Issue 8, 2010, Pages 741-743

  Klinke, J A ^a   Shapira, S C ^a   Akbari, E ^b   Holmes, D T ^b  

^a ROYAL COLUMBIAN HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; CHOLESTEROL; COLESTYRAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INFUSION FLUID; INSULIN; LAMOTRIGINE; LIPOPROTEIN X; LITHIUM; QUETIAPINE; SODIUM; TRIACYLGLYCEROL; URSODEOXYCHOLIC ACID; ZOPICLONE;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; BILE DUCT INJURY; BIPOLAR DISORDER; CASE REPORT; CHOLESTASIS; CHOLESTEROL BLOOD LEVEL; CONSERVATIVE TREATMENT; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ELECTROPHORESIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FECES COLOR; HEPATOSPLENOMEGALY; HISTOLOGY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; HYPONATREMIA; INSULIN DEPENDENT DIABETES MELLITUS; JAUNDICE; LIVER BIOPSY; MALAISE; MALE; NEPHELOMETRY; NEUTROPHIL; PRIORITY JOURNAL; PRURITUS; PSEUDOHYPONATRAEMIA; URINE COLOR;

ADULT; ANTIPSYCHOTIC AGENTS; CHOLESTASIS, INTRAHEPATIC; DIBENZOTHIAZEPINES; HUMANS; HYPERCHOLESTEROLEMIA; HYPONATREMIA; LIPOPROTEIN-X; MALE;

EID: 77955740760     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.064063     Document Type: Article

References (10)

1. Wright TM, Vandenberg AM. Risperidone- and quetiapine-induced cholestasis. Ann Pharmacother 2007;41:1518-23.
2. Moller KE, Wei L, Jewell AD, et al. Acute hepatotoxicity associated with lamotrigine. Am J Psychiatry 2008;165:539-40.
3. Seidel D, Alaupovic P, Furman RH. A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Invest 1969;48:1211-23.
4. Seidel D. Lipoproteins in liver disease. J Clin Chem Clin Biochem 1987;25:541-51.
5. Santamarina-Fojo S, Hoeg JM, Assmann G, et al. Lecithin cholesterol acyltransferase deficiency and fish eye disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 8th edn. New York: McGraw-Hill, 2001:2817-33.
6. Manzato E, Fellin R, Baggio G, et al. Formation of lipoprotein-X: its relationship to bile compounds. J Clin Invest 1976;57:1248-60.
7. Peynet J, Feneant-Thibault M, Legrand A, et al. Isolation and characterization of an abnormal alpha slow-moving high density lipoprotein subfraction in serum from children with long-standing cholestasis. Clin Chem 1986;32:646-51. (Pubitemid 17027206)
8. Miyahara K, Kasahara N, Kondo Y, et al. Changes in plasma lipids and abnormal lipoproteins in a patient with drug-induced cholestatic hepatitis. Jpn J Med 1991;30:354-9.
9. Twomey PJ, Don-Wauchope AC, McCullough D. Unreliability of triglyceride measurement to predict turbidity induced interference. J Clin Pathol 2003;56:861-2.
10. Turchin A, Seifter JL, Seely EW. Clinical problem-solving. Mind the gap. N Engl J Med 2003;349:1465-9.